Details of the Drug
General Information of Drug (ID: DMMSFEU)
Drug Name |
2-(1-adamantyl) pyrrolidine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-(1-adamantyl)pyrrolidine; 2-(adamantan-1-yl)pyrrolidine; 180258-96-2; 2-Adamantan-1-yl-pyrrolidine; 2-(tricyclo[3.3.1.1~3,7~]dec-1-yl)pyrrolidine; AC1LADDP; SCHEMBL587943; CHEMBL323901; CTK5J7450; YVRRAISBZUMEJB-UHFFFAOYSA-N; MolPort-004-320-513; ALBB-007403; ZX-AN006941; BBL022461; STK504519; AKOS016345558; AKOS000157977; RTR-059731; MCULE-4533332464; ACM180258962; TR-059731; W-9623; Pyrrolidine, 2-tricyclo[3.3.1.1~3,7~]dec-1-yl-, (2S)-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 205.34 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||